InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.010 0.001 (11.11%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Letter to Shareholders - Notice of General Meeting 30 Jan 2024 11:06AM $0.165 $0.010 fallen by 93.94%
$28 Notice of General Meeting/Proxy Form 30 Jan 2024 11:05AM $0.165 $0.010 fallen by 93.94%
$28 NDA Resubmission Accepted and Approval Date Confirmed 22 Jan 2024 8:29AM $0.175 $0.010 fallen by 94.29%
$28 Section 708A(5)(e) Notice 15 Jan 2024 7:49PM $0.190 $0.010 fallen by 94.74%
$28 Application for quotation of securities - BOT 15 Jan 2024 7:42PM $0.190 $0.010 fallen by 94.74%
$28 Section 708A(5)(e) Notice 8 Jan 2024 5:57PM $0.180 $0.010 fallen by 94.44%
$28 Application for quotation of securities - BOT 8 Jan 2024 5:54PM $0.180 $0.010 fallen by 94.44%
$28 Botanix Resubmission of NDA for Sofdra Completed 21 Dec 2023 9:11AM $0.165 $0.010 fallen by 93.94%
$28 Successful Completion of Human Factors Study 14 Dec 2023 9:10AM $0.145 $0.010 fallen by 93.10%
$28 Section 708A(5)(e) Notice 7 Dec 2023 6:39PM $0.150 $0.010 fallen by 93.33%
$28 Application for quotation of securities - BOT 7 Dec 2023 6:33PM $0.150 $0.010 fallen by 93.33%
$28 FDA Confirms Approach to Sofdra NDA Resubmission 4 Dec 2023 8:21AM $0.165 $0.010 fallen by 93.94%
$28 Section 708A(5)(e) Notice 1 Dec 2023 9:51AM $0.165 $0.010 fallen by 93.94%
$28 Successful Completion of $13.5m Institutional Placement 1 Dec 2023 9:42AM $0.165 $0.010 fallen by 93.94%
$28 Notification regarding unquoted securities - BOT 1 Dec 2023 9:12AM $0.165 $0.010 fallen by 93.94%
$28 Application for quotation of securities - BOT 1 Dec 2023 9:09AM $0.165 $0.010 fallen by 93.94%
$28 Proposed issue of securities - BOT 27 Nov 2023 9:36AM $0.155 $0.010 fallen by 93.55%
$28 Botanix Placement Secures $13.5M to Fund Sofdra Launch Prep 27 Nov 2023 9:36AM $0.155 $0.010 fallen by 93.55%
$28 Trading Halt 23 Nov 2023 9:38AM $0.155 $0.010 fallen by 93.55%
$28 Results of Annual General Meeting 8 Nov 2023 2:38PM $0.140 $0.010 fallen by 92.86%
$28 Annual General Meeting Presentation 8 Nov 2023 9:46AM $0.140 $0.010 fallen by 92.86%
$28 Annual General Meeting - Chairman's Address 8 Nov 2023 9:42AM $0.140 $0.010 fallen by 92.86%
$28 Investor Presentation and Investor Meetings 31 Oct 2023 9:45AM $0.140 $0.010 fallen by 92.86%
$28 September 2023 Quarterly Activities Report and Appendix 4C 31 Oct 2023 9:00AM $0.140 $0.010 fallen by 92.86%
$28 Botanix Partners with Telehealth Provider UpScriptHealth 24 Oct 2023 9:43AM $0.125 $0.010 fallen by 92%

226 - 250 of 726 results

Page 10 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.